Home | MyCME | All CME | Blog | Psychlopedia

Current CME Activities

CME Activities From Our Journals

Online CME Activities

+JCP CME Activities [Series Home Page]

Grigoriadis et al

JCP CME

Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis

Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter

Activity | Posttest | Credits: 1.00 | Expires: 8/30/2021 | Keywords: Antidepressants, Anxiety, Anxiolytics, Depression, Women’s Mental Health

Is prenatal benzodiazepine use associated with an increased risk of congenital malformations? What about concurrent use of a benzodiazepine and an antidepressant? Does the trimester have an effect? See what these reviewers found.

Babinski et al

JCP CME

Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence

Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2022 | Keywords: Attention-Deficit/Hyperactivity Disorder, Depression, Child and Adolescent Psychiatry

Despite the high risk for depression, not all youth with ADHD develop a mood disorder. Which children are at highest risk? How does early or late puberty affect the risk?

Olfson et al

JCP CME

Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2021 | Keywords: Anxiety, Depression, Substance Use Disorders

When patients present for treatment of anxiety or mood disorders, do you consider whether there is also an untreated substance use disorder? Check out these data on disorder prevalence and treatment rates.

Weiss et al

JCP CME

Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence

Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2021 | Keywords: Substance Use Disorders, Psychotherapy

Which treatments are strongly associated with opioid abstinence over time among patients with prescription opioid dependence: Opioid agonists? Outpatient counseling? Mutual-help group attendance?

Chen et al

JCP CME

Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study

Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2021 | Keywords: Bipolar Disorder, Child and Adolescent Psychiatry, Mood Disorders, Sexual Dysfunction

What are some risk factors for (and protective factors against) sexually transmitted infections among adolescents and young adults with bipolar disorder?

Dobson et al

JCP CME

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2021 | Keywords: Anxiety, Antidepressants, Anxiolytics, Child and Adolescent Psychiatry

Medications can reduce anxiety in children and adolescents, but treatment response, tolerability, and treatment-emergent suicidality differ among these medications and medication classes. Read this journal CME article to learn about meta-analysis results.

Misdrahi et al

JCP CME

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort

David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2021 | Keywords: Schizophrenia/Schizoaffective Disorders, Side Effects, Antipsychotics, Movement Disorders, Tardive Dyskinesia, Neurology

When you see patients taking antipsychotics, do you systematically evaluate them for extrapyramidal side effects? Read this CME journal article for data on risk factors associated with drug-induced parkinsonism and tardive dyskinesia.

Rej et al

JCP CME

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults

Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2020 | Keywords: Bipolar Disorder, Depression, Geriatric Psychiatry, Mood Disorders

Do you have older patients who are taking lithium? If so, have you checked the recommended frequencies for blood monitoring in older adults? Read this journal CME article to find out about appropriate laboratory monitoring.

Shiner et al

JCP CME

A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2020 | Keywords: Posttraumatic Stress Disorder, Veterans and Military Issues

How do treatments for posttraumatic stress disorder (PTSD) compare in routine clinical practice? Read this CME retrospective study of patient records for a look at real-life outcomes. Patients were taking fluoxetine, paroxetine, sertraline, topiramate, or venlafaxine, and some had concurrent psychotherapy.

Ginsburg et al

JCP CME

An Examination of Screening Tools for Collaborative Care of Adolescent Depression

Alexander D. Ginsburg, Paul S. Stadem, Christopher R. Takala, Paul E. Croarkin, Angela B. Mattson, Marcie L. Billings, RoxAnne M. Brennan, and John E. Huxsahl

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2020 | Keywords: Depression, Anxiety, Substance Use Disorders, Delivery of Care, Mood Disorders, Child and Adolescent Psychiatry

Is your health system using a collaborative care model to provide high-quality care to patients? Do you know what factors might influence treatment outcomes among adolescents with depression who receive collaborative care? Read this CME journal article to learn more.

Moeller et al

JCP CME

Trends in Illicit Drug Use Among Smokers and Nonsmokers in the United States, 2002–2014

Scott J. Moeller, PhDa; David S. Fink, MPHb; Misato Gbedemah, MPHc; Deborah S. Hasin, Sandro Galea, Michael J. Zvolensky, and Renee D. Goodwin

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2020 | Keywords: Substance Use Disorders, Smoking, None, None, None, None

How common is illicit drug use among current and former cigarette smokers? If marijuana isn't considered illicit, does that change the prevalence of illicit drug use? Can illicit drug use interfere with smoking abstinence? Learn about these topics in this CME journal article.

Wetherell et al

JCP CME

Mindfulness-Based Stress Reduction for Older Adults With Stress Disorders and Neurocognitive Difficulties: A Randomized Controlled Trial

Julie Loebach Wetherell, Tamara Hershey, Steven Hickman, Susan R. Tate, David Dixon, Emily S. Bower, and Eric J. Lenze

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2019 | Keywords: Anxiety, Geriatric Psychiatry, Cognition, Neurology, Complementary and Alternative Medicine, Psychotherapy

Are you familiar with mindfulness-based stress reduction (MBSR)? This intervention, which combines meditation and yoga, might appeal to your older patients for relief from depression and worry and may also aid memory. Learn more about MBSR in this journal CME activity.

+PCC CME Activities [Series Home Page]

Hager et al

PCC CME

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics (HDC/DFMC Bridge Project—Phase 1: Group Concept Mapping)

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2021 | Keywords: Antipsychotics, Health Services, Integrated Care, Medical Conditions, Metabolic Disorders

Care coordination across health systems is critical to optimize patient care for chronic medical and psychiatric conditions. Group concept mapping provides a strategic process to allow shared-decision making among stakeholders.

Netto et al

PCC CME

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2022 | Keywords: Bipolar Disorder, Schizophrenia/Schizoaffective Disorders, Antipsychotics

Lithium neurotoxicity, both reversible and irreversible, can occur when lithium is combined with second-generation antipsychotics. Early detection and prompt management are needed. Do you know the causative factors?

Kachadourian et al

PCC CME

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2021 | Keywords: Posttraumatic Stress Disorder, Veterans and Military Issues, Depression, Sleep, Cognition, Suicide

How would you use a symptom-focused approach to provide a more nuanced method for the assessment, monitoring, and treatment of PTSD?

Schreiber et al

PCC CME

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2021 | Keywords: Bipolar Disorder, Depression, Schizophrenia/Schizoaffective Disorders, Anxiety

Psychotropic medications provide therapeutic benefits but also carry iatrogenic risks. Medication monitoring helps minimize this risk. This CME journal article offers clinicians a review of guidelines and presents monitoring recommendations with a convenient 1-page quick guide.

Gautam and Prabhakar

PCC CME

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2020 | Keywords: Attention-Deficit/Hyperactivity Disorder, Stimulants

Various formulations of methylphenidate and amphetamine are approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). The drug delivery mechanisms of these compounds create unique parameters that differ considerably among the formulations. This CME article is a comprehensive guide for prescribing clinicians.

Martz et al

PCC CME

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2020 | Keywords: Substance Use Disorders, Child and Adolescent Psychiatry

What do you know about the use of synthetic marijuana among adolescents? Read this CME article to learn about why they use it, what the risks are, and whether they perceive it as dangerous.

Fehr et al

PCC CME

Posttraumatic Stress Disorder Comorbid with Mood Disorder: Significantly Higher Incidence of Obstructive Sleep Apnea Than Either Diagnosis Alone

Bettina S. Fehr, William F. Katz, Erin A. Van Enkevort, and Imran S. Khawaja

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2020 | Keywords: Sleep, Posttraumatic Stress Disorder, Depression, Bipolar Disorder, Comorbidity, Mood Disorders

Do you screen for sleep disorders in patients with psychiatric conditions? Symptom overlap can mean that sleep disorders such as obstructive sleep apnea are overlooked in patients with posttraumatic stress disorder and mood disorders. Read this CME article to learn about screening and evaluation.

Weidman et al

PCC CME

To Scan or Not to Scan: Horses and Zebras

David A. Weidman, Anna D. Burke, Jennifer M. Eschbacher, Jacquelynn N. Copeland, Michele Grigaitis-Reyes, and William J. Burke

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2020 | Keywords: Dementia, Alzheimer Disease, Medical Conditions, Neurology, Neuroimaging, None

When evaluating an older patient for possible dementia, do you order neuroimaging? Work through this CME case to learn about an 87-year-old woman who presented with her family to Banner Alzheimer’s Institute for evaluation and treatment of cognitive impairment.

Jafferany and Pastolero

PCC CME

Psychiatric and Psychological Impact of Chronic Skin Disease

Mohammad Jafferany and Paul Pastolero

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2020 | Keywords: Medical Conditions, Depression, Dermatology, Psychotherapy, None, None

Have you considered how conditions such as atopic dermatitis, acne, vitiligo, psoriasis, and alopecia affect your patients? Skin disease can be associated with anxiety, anger, depression, social isolation, and low self-esteem. Read this CME journal article to learn about recognizing and treating psychological problems in patients with skin diseases and communicating with patients in a culturally competent manner.

Jafferany et al

PCC CME

Psychological Aspects of Factitious Disorder

Mohammed Jafferany, Zaira Khalid, Katherine A. McDonald, and Amanda J Shelley

Activity | Posttest | Credits: 1.00 | Expires: 2/29/2020 | Keywords: Neurology, Psychotic Disorders, Factitious Disorder, None, None, None

When you suspect that a patient is fabricating his or her illness, how do you proceed? Read this CME article to learn more about the warning signs, differential diagnosis, and management of factitious disorder.

Guirguis et al

PCC CME

Are Psychiatric Inpatients at Risk of Developing Wernicke’s Encephalopathy Being Identified and Adequately Treated?

Medhat Guirguis, Stephen Manning, Marina Chavez, Jessica Nelson, Regina Baronia, Sailatha Bobba, Jafreen Ahmed, and Ijeoma Ajufo

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2019 | Keywords: Substance Use Disorders, Medical Conditions, Eating Disorders, Encephalitis, Neurology, None

Wernicke’s encephalopathy results from thiamine deficiency and, if untreated, can lead to significant neurologic sequelae or death. Did you know that autopsy reports indicate that three-fourths of Wernicke’s encephalopathy cases were not diagnosed before death? Read this CME article to learn about how you can better diagnose and treat this medical emergency.

Joseph M. Trombello, et al

PCC CME

Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program

Joseph M. Trombello, Charles South, Audrey Cecil, Katherine E. Sánchez, Alma Christina Sánchez, Sara Levinson Eidelman, Taryn L. Mayes, Farra Kahalnik, Corey Tovian, Beth D. Kennard, and Madhukar H. Trivedi

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2019 | Keywords: Depression, Anxiety, Delivery of Care, Psychotherapy, Complementary and Alternative Medicine, None

Research on behavioral activation (BA) teletherapy is limited. Learn about a brief BA teletherapy program for depression and anxiety in a study describing results among low-income, real-world primary care patients.

+New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder [Series Home Page]

Citrome et al

Audio Summary

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD

Activity | Posttest | Credits: 1.50 | Expires: 8/30/2022 | Keywords: Depression, Antidepressants, Suicide, Mood Disorders

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019 ASCP Annual Meeting.

+A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease [Series Home Page]

Shaughnessy et al

Brief Report

Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD

Activity | Posttest | Credits: 1.50 | Expires: 6/30/2021 | Keywords: Alzheimer Disease, Cognition, Dementia, Diagnostic Tools

Meaningful benefits can be derived from the evaluation of cognition in older adults when there is possible cognitive impairment and dementia. In this CME activity, experts explain how brief cognitive assessment tools and neuropsychological evaluations can aid diagnosis and inform a management plan.

Goldfarb et al

Brief Report

Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication

Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2021 | Keywords: Alzheimer Disease, Neurology, Dementia

Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. But doing so in a timely fashion benefits patients and their care partners. In this CME activity, learn about using patient-centered communication and following a structured process to disclose the diagnosis.

+Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia [Series Home Page]

Lauriello and Perkins

Webcast

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

John Lauriello, MD and Diana O. Perkins, MD

Activity | Posttest | Credits: 2.00 | Expires: 3/31/2021 | Keyword: Schizophrenia/Schizoaffective Disorders

Relapse of schizophrenia often occurs due to treatment nonadherence. Long-acting injectable (LAI) antipsychotics can improve adherence but are underused. Watch this Webcast to hear interviews with patients and learn from experts how LAIs may translate into clinical benefit.

Lauriello and Perkins

JCP CME

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

John Lauriello, MD, and Diana O. Perkins, MD

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2021 | Keywords: Schizophrenia/Schizoaffective Disorders, Adherence, Antipsychotics, Psychotic Disorders

Interruptions in treatment increase the risk of relapse in patients with schizophrenia. Read this Academic Highlights to learn about factors that contribute to nonadherence, effective methods for monitoring adherence, and strategies for ensuring continuous treatment.

+Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder [Series Home Page]

Melissa DelBello

Brief Report

Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents

Melissa P. DelBello, MD, MS

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2020 | Keywords: Bipolar Disorder, Child and Adolescent Psychiatry, Education

Children whose bipolar disorder is inadequately treated often grow into adults who are unable to manage their illness. Read this new Brief Report to discover the most effective treatment strategies to help patients and families learn to control and cope with their bipolar disorder, particularly episodes of depression, as they advance towards adulthood.

Manpreet K. Singh

Brief Report

Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients

Manpreet K. Singh, MD, MS

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2020 | Keywords: Bipolar Disorder, Depression, Child and Adolescent Psychiatry, Diagnostic Tools

At least half of the cases of bipolar disorder begin in childhood or adolescence. How do you decide whether a young patient's symptoms indicate bipolar disorder? Read this CME Brief Report to learn about reliable tools and methods to identify bipolar disorder in pediatric patients.

+Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments [Series Home Page]

Lipton and Silberstein

PCC CME

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments

Richard B. Lipton, MD, and Stephen Silberstein, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2020 | Keywords: Medical Conditions, Neurology, Migraine, Headache

Most people with primary headache disorders, such as migraine, are undiagnosed. Read this PCC Supplement for updated classifications and assessments for patients with headache disorders and ways to identify and educate patients who are candidates for preventive treatment.

+Current and Emerging Treatments to Address Unmet Needs in MDD [Series Home Page]

Michael E. Thase

Brief Report

Current and Emerging Treatments to Address Unmet Needs in MDD

Michael E. Thase, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2020 | Keywords: Depression, Antidepressants

Most people who experience a depressive episode are greatly impaired by it. No one-size-fits-all therapy is available, and most patients require multiple treatment steps. Check out this CME activity to learn about current and emerging strategies for managing MDD.

+Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder [Series Home Page]

Roger S. McIntyre

Brief Report

Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2020 | Keywords: Depression, Side Effects

Despite the availability of effective treatments for MDD, many individuals have difficulty achieving remission. Residual symptoms can be difficult to differentiate from treatment side effects. Through 2 comic-based case presentations, this CME activity depicts common clinical scenarios and provides evidence-based strategies for effectively identifying and managing residual symptoms of MDD.

+Effective Management Approaches for Psychosis in Patients With Parkinson Disease [Series Home Page]

Pahwa and Kremens

Journal Supplement

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Rajesh Pahwa, MD (Chair), and Daniel E. Kremens, MD, JD

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2020 | Keywords: Psychotic Disorders, Neurology, Parkinson Disease

Are you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement by 2 experts in the field for an update on PDP symptoms and treatments.

+Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder [Series Home Page]

Findling and Chang

JCP CME

Improving the Diagnosis and Treatment of Pediatric Bipolar Disorder

Robert L. Findling, MD, MBA (chair), and Kiki D. Chang, MD

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2020 | Keywords: Bipolar Disorder, Child and Adolescent Psychiatry, None, None, None, None

Pediatric patients with bipolar disorder are at risk for poor long-term outcomes, but with careful screening, clinicians may be able to detect early signs or symptoms. Read this CME Academic Highlights in which experts discuss recognition and diagnosis of bipolar disorder in the pediatric population and options for effective treatment.

Robert L. Findling

Brief Report

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Activity | Posttest | Credits: 0.50 | Expires: 1/31/2020 | Keywords: Bipolar Disorder, Child and Adolescent Psychiatry, Antipsychotics, Anticonvulsants, None, None

How do you select among treatments for bipolar disorder in adolescents? Check out this brief report activity to explore the efficacy and safety of lithium, anticonvulsants, and atypical antipsychotics in the treatment of adolescent bipolar disorder. Plus, receive guidance for monitoring for common adverse effects, such as weight gain and fatigue.

Kiki D. Chang

Brief Report

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Activity | Posttest | Credits: 0.50 | Expires: 1/31/2020 | Keywords: Bipolar Disorder, Child and Adolescent Psychiatry, Diagnostic Tools, None, None, None

As many as 2 million youths in the US alone could have bipolar disorder. In this CME brief report, get up-to-date on common presentations of pediatric bipolar disorder, DSM-5 diagnostic criteria, and structured interviews and screening tools that can help you detect manic symptomatology.

+Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis [Series Home Page]

Jain and Correll

JCP CME

Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis

Rakesh Jain, MD, MPH (Chair), and Christoph U. Correll, MD

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2020 | Keywords: Schizophrenia/Schizoaffective Disorders, Bipolar Disorder, Depression, Movement Disorders, Tardive Dyskinesia, Neurology

Tardive dyskinesia (TD) is an involuntary movement disorder associated with antipsychotic treatment. Because of the serious and potentially irreversible nature of TD, accurate diagnosis is crucial. However, the risk may be underestimated, and diagnosing TD can be challenging, with early signs easily missed. To learn more, read this ACADEMIC HIGHLIGHTS, in which experts review the prevalence, phenomenology, risk factors, and impact of TD, illustrated by case examples, and provide valuable clinical information to guide early recognition and accurate diagnosis.

+Parkinson Disease: Current Trends in Treatment and Unmet Needs [Series Home Page]

Adolfo Ramirez-Zamora

Brief Report

Parkinson Disease: Current and Emerging Treatment Strategies

Adolfo Ramirez-Zamora, MD

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2020 | Keywords: Neuropsychiatric Disorders, Depression, Movement Disorders, Sleep, Neurology, Parkinson Disease

Although levodopa is effective for treating Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients may develop fluctuations in motor symptoms and dyskinesias as well as nonmotor symptoms. Review this CME Brief Report activity to learn about new and emerging treatment options to manage patients’ symptoms.

+Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice [Series Home Page]

Ruth M. Benca and Daniel J. Buysse

JCP CME

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Ruth M. Benca, MD, PhD, and Daniel J. Buysse, MD

Activity | Posttest | Credits: 1.00 | Expires: 2/29/2020 | Keywords: Sleep, Neurology, None, None, None, None

Insomnia is often considered a symptom of psychiatric disorders when it actually needs to be addressed as a separate disorder. Read this CME Academic Highlights in which experts discuss ways to evalute patients with insomnia and to safely and effectively implement behavioral and pharmacologic treatments.

Ruth M. Benca and Daniel J. Buysse

Podcast

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 2

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2019 | Keywords: Sleep, Neurology, Posttraumatic Stress Disorder, Comorbidity, Depression, Substance Use Disorders

Tune in to this podcast as experts discuss 2 patient cases—one involving co-occurring insomnia and depression and another comprising PTSD, substance abuse, insomnia, and nightmares. Drs Benca and Buysse explain how to effectively diagnose and manage these complex cases based on the latest diagnostic criteria and evidence from clinical trials.

Ruth M. Benca and Daniel J. Buysse

Podcast

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 1

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2019 | Keywords: Sleep, Bipolar Disorder, Schizophrenia/Schizoaffective Disorders, Neurology, None, None

Listen to this podcast as experts discuss 2 patient cases focusing on diagnosing and treating co-occurring insomnia and mental illness. The first case features a 32-year-old man with bipolar disorder who is experiencing psychiatric symptoms and poor sleep, and the second case involves a 27-year-old man with schizophrenia who is having auditory hallucinations as well as chronic issues with insomnia.

+Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management [Series Home Page]

Larry Culpepper (Chair) et al

Podcast

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2020 | Keywords: Depression, Cognition, None, None, None, None

How can you help your patients who are experiencing both depression and cognitive dysfunction? Tune in to this CME podcast to hear experts in psychiatry discuss 2 patient cases that illustrate the burden of cognitive impairment in major depressive disorder as well as effective assessment tools and management strategies.

Larry Culpepper (Chair), et al

JCP CME

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Larry Culpepper, MD, MPH; Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2019 | Keywords: Depression, Cognition, Diagnostic Tools, None, None, None

Is cognitive impairment keeping your patients with MDD from achieving full functional recovery? In this Academic Highlights, leading experts in MDD discuss the burden associated with cognitive impairment, effective strategies for assessing cognitive function, and available pharmacologic and nonpharmacologic treatment options.

Larry Culpepper

Brief Report

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2019 | Keywords: Depression, Cognition, Neurology, None, None, None

Pronounced deficits in executive function are found in up to one-third of patients with MDD, and this impairment can keep patients from achieving full functional recovery. In this CME activity, review the evidence regarding the effectiveness of available interventions to improve cognitive dysfunction in patients with MDD. "

Raymond W. Lam

Brief Report

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2019 | Keywords: Depression, Cognition, Neurology, None, None, None

For patients with depression, a return to normal functioning is a key treatment goal. Yet many of these patients demonstrate cognitive impairment even after they reach remission. In this CME activity, learn more about the association between cognitive dysfunction and work functioning, and find information on rating scales that measure functioning.

Roger S. McIntyre

Brief Report

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2019 | Keywords: Depression, Cognition, Diagnostic Tools, Neurology, None, None

You know that measuring cognition in your patients with depression is important. But cognitive assessment instruments can be difficult to access, expensive, time consuming, and not available in an electronic format. Read this CME activity to learn about a new free tool.

+Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? [Series Home Page]

Correll and Lauriello

Webcast

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U. Correll, MD, and John Lauriello, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Bipolar Disorder, Adherence, Antipsychotics, None, None

Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor LAI treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders.

+What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options [Series Home Page]

Joseph P. McEvoy

Case & Comment

Evidence-Based Strategies for Managing Tardive Dyskinesia

Joseph P. McEvoy, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2019 | Keywords: Bipolar Disorder, Medical Conditions, Tardive Dyskinesia, Neurology, None, None

Do you know how to treat tardive dyskinesia symptoms? In this new Case and Comment activity, consider the case of John, a 25-year-old project manager diagnosed with bipolar disorder who has begun exhibiting symptoms of uncontrollable movement.

Manning and McEvoy

Webcast

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

J. Sloan Manning, MD, Joseph P. McEvoy, MD

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Antipsychotics, Tardive Dyskinesia, Neurology, None, None

Do you know which of your patients are at risk for developing tardive dyskinesia? Watch this new webcast to learn about how to prevent TD in your patients and new treatment strategies for your patients who have already been diagnosed.

J. Sloan Manning

Case & Comment

Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs

J. Sloan Manning, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2019 | Keywords: Depression, Medical Conditions, Antipsychotics, Tardive Dyskinesia, Neurology, None

Your patients taking antipsychotics may be at risk for developing tardive dyskinesia. In this new Case and Comment activity, follow Martha, a 60-year-old woman being treated with an antipsychotic medication for her treatment-resistant depression.

+Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach [Series Home Page]

+Emerging Treatment Strategies for Patients With Tardive Dyskinesia [Series Home Page]

Christoph U. Correll (Chair), et al

JCP CME

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Neurology, Tardive Dyskinesia, None, None, None

Is your patient experiencing involuntary movements of the face, torso, or extremities? It could be tardive dyskinesia, a side effect of antipsychotic medications. Explore this CME Academic Highlights activity to find out who’s at risk for developing tardive dyskinesia and how it can be prevented. Plus, learn about assessment strategies and tools as well as evidence for treatments.

John M. Kane

Brief Report

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Bipolar Disorder, Antipsychotics, Neurology, Tardive Dyskinesia, Diagnostic Tools

Do you regularly screen for tardive dyskinesia in at-risk patients? Explore this CME activity by a well-known expert for information on rating scales for screening, available diagnostic criteria, assessment tips, and monitoring recommendations.

Leslie L. Citrome

Brief Report

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Bipolar Disorder, Depression, Antipsychotics, Neurology, Tardive Dyskinesia

Many treatment interventions for tardive dyskinesia have been studied, but some have better evidence than others. Read this CME activity to get an expert's perspectives on the evidence for older and newer treatments so that you can minimize abnormal movements in your patients.

Christoph U. Correll

Brief Report

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2019 | Keywords: Schizophrenia/Schizoaffective Disorders, Bipolar Disorder, Depression, Tardive Dyskinesia, Neurology, Antipsychotics

What risk factors suggest that patients are more likely to develop tardive dyskinesia (TD)? Can TD symptoms be prevented? Read this CME activity to learn about the prevalence, epidemiology, and prevention of these abnormal movements from an expert.

+Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics? [Series Home Page]

+Diagnosing and Treating Patients With Mixed Features [Series Home Page]

Rakesh Jain (Chair) et al

JCP CME

Diagnosing and Treating Patients With Mixed Features

Rakesh Jain, MD, MPH (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2019 | Keywords: Depression, Bipolar Disorder, None, None, None, None

Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they review the current diagnostic criteria for depressive episodes with mixed features, the risk of developing bipolar disorder in patients with this diagnosis, and recent treatment guidelines.

+Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission [Series Home Page]

+Challenges in the Recognition and Treatment of Binge-Eating Disorder [Series Home Page]

+Recognition and Treatment of Pediatric Bipolar Disorder [Series Home Page]

+Improving the Care and Management of Patients With Inadequate Response to Depression Treatment [Series Home Page]

+Enhancing Approaches to the Identification and Management of Pseudobulbar Affect [Series Home Page]

+Achieving Remission and Recovery in Depression With Anxiety [Series Home Page]

+Measuring and Managing Cognitive Impairment in Schizophrenia [Series Home Page]

+Sleep Disorders in the Psychiatric Setting [Series Home Page]

+Strategies to Improve Outcomes for Primary Care Patients With Major Depressive Disorder [Series Home Page]

+Recognizing and Treating Excessive Daytime Sleepiness and Narcolepsy [Series Home Page]

+Complicated Major Depressive Disorder [Series Home Page]

+What Psychiatric Nurses Need to Know About Bipolar Disorder [Series Home Page]

+Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression [Series Home Page]

+Barriers to Remission in Major Depressive Disorder: Residual Symptoms, Functional Impairment, and Medication Mechanism of Action [Series Home Page]

+Criminal Forensic Psychiatry [Series Home Page]

+Cognition in the Depressed Patient [Series Home Page]

+Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective [Series Home Page]

+Overcoming Challenges in the Diagnosis and Management of ADHD in African American Adults [Series Home Page]

+Cause and Effect in Bipolar Depression: Misdiagnosis Leads to Inappropriate Treatment, Clinical Complications, and Adverse Outcomes [Series Home Page]

+New Strategies in Sleep [Series Home Page]

+Challenges in the Recognition and Management of ADHD in Hispanic Adults in the United States [Series Home Page]

+Making Connections Between Science and Symptoms in Schizophrenia [Series Home Page]

+Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

+Treating and Caring for the Patient With Moderate-to-Severe Alzheimer's Disease [Series Home Page]

+The Impact of Oral Medications on the Treatment of Multiple Sclerosis [Series Home Page]

+Improving Depression Outcomes by Providing Safe and Effective Care in the Rural Setting [Series Home Page]

+Depression: Addressing Partial Response After First-Line Antidepressant Treatment [Series Home Page]

+Controversies in the Psychopharmacology of Bipolar Disorder [Series Home Page]

+Poster Sessions From The 2014 ASCP Annual Meeting [Series Home Page]

+Appropriate Management of Multiple Sclerosis in Primary Care [Series Home Page]

+Update on Best Practices for Managing Bipolar Depression [Series Home Page]

+Measurement-Based Strategies to Assess and Manage Schizophrenia    [Series Home Page]

+Benefits and Barriers to Using Long-Acting Injectable Antipsychotics in Schizophrenia [Series Home Page]

+Improving the Diagnosis and Management of Depression in Bipolar Disorder [Series Home Page]

+Improving the Differential Diagnosis and Treatment of Bipolar Depression in Primary Care [Series Home Page]

+Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies [Series Home Page]

+Restless Legs Syndrome: Recognition, Diagnosis, and Treatment of a Common Sleep Disorder [Series Home Page]

+Treatment of Depression in Primary Care: Using Tools to Improve Outcomes [Series Home Page]

+Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission [Series Home Page]

+Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call To Action [Series Home Page]

+Complicated OCD: Issues of Comorbidity and Clinical Challenges [Series Home Page]

+Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System [Series Home Page]

+Assessing and Managing Pain and Major Depression With Medical Comorbidities [Series Home Page]

+Schizophrenia: Using Long-Acting Injectable Antipsychotics to Improve Treatment Adherence [Series Home Page]

+The Effects of the Affordable Care Act on the Practice of Psychiatry [Series Home Page]

+ADHD in College, Phase II: Managing the Risk of Misuse, Abuse, and Diversion [Series Home Page]

+Caring for Returning Veterans: Meeting Mental Health Needs [Series Home Page]

+Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management [Series Home Page]

+Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences [Series Home Page]

+Expired Other [Series Home Page]

+Negative Symptoms in Schizophrenia: Treatment Gaps and Unmet Needs [Series Home Page]

+The Effect of Marijuana Use on the Risk for Schizophrenia [Series Home Page]

+Depression, Pain, and Comorbid Medical Conditions [Series Home Page]

+Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management [Series Home Page]

+A Fresh Look at Monoamine Oxidase Inhibitors for Depression [Series Home Page]

+NCDEU Poster Session 2012 [Series Home Page]

+The Appropriate Use of Opiates in Chronic Pain [Series Home Page]

+Multiple Sclerosis Syndromes and Symptoms: A Clinical Primer [Series Home Page]

+New Treatment Approaches for Major Depressive Disorder   [Series Home Page]

+Bipolar Disorder: Lessons for Rural Physicians: Adjunctive Interventions for Maintaining Remission [Series Home Page]

+Schizophrenia: When First-Line Treatment Fails [Series Home Page]

+Diagnosing and Managing Patients With Dementia [Series Home Page]

+ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult [Series Home Page]

+Overview of Current Issues in the Management of Multiple Sclerosis [Series Home Page]

+International Consensus Group on Depression Prevention in Bipolar Disorder [Series Home Page]

+Alzheimer's Disease: Implications of the Updated Diagnostic and Research Criteria [Series Home Page]

+Fibromyalgia: Creating a Patient-Centered Diagnostic and Therapeutic Roadmap [Series Home Page]

+2011 ICBD Conference Coverage: Practical Applications of New Research in Bipolar Disorder [Series Home Page]

+Evidence for Using L-Methylfolate Combined With Antidepressants in MDD [Series Home Page]

+Depression: When Initial Therapy Fails [Series Home Page]

+Using Diagnostic and Assessment Tools for Adolescents With ADHD [Series Home Page]

+Using Moderator-Based Algorithms  and Electronic Medical Records  to Achieve Optimal Outcomes in Depression [Series Home Page]

+The Current Crisis of Confidence in Antidepressants [Series Home Page]

+New Approaches to Managing Schizoaffective Disorder From Diagnosis to Treatment [Series Home Page]

+Looking Past First-Line Therapy for Major Depressive Disorder [Series Home Page]

+Considerations in Managing Schizophrenia in Adolescents [Series Home Page]

+Challenges in the Long-Term Treatment of Schizophrenia [Series Home Page]

+Improving Outcomes in Bipolar Disorder: From Early Recognition and Treatment to Remission [Series Home Page]

+Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain [Series Home Page]

+Strategies for the Long-Term Treatment of Bipolar Disorder in Children and Adults [Series Home Page]

+Improving the Recognition and Treatment of Bipolar Disorder in Primary Care [Series Home Page]

+Improving Executive Function in Adults With ADHD [Series Home Page]

+Improving Outcomes in Depression [Series Home Page]

+International Consensus Group on Depression [Series Home Page]

+Debates and Directions in Fibromyalgia: Recognizing Signs and Selecting the Appropriate Paths [Series Home Page]

+Tackling Partial Remission to Depression Treatment [Series Home Page]

+The Use of Complementary and Alternative Medicines to Achieve Remission in Major Depressive Disorder [Series Home Page]

+What Is Bipolar Disorder? [Series Home Page]

+An Introduction to the Clinical Correlates of Disrupted Slow-Wave Sleep [Series Home Page]

+Following Up on The Expert Consensus Guidelines for Geriatric Depression [Series Home Page]

+Depression in Latinos: A Focus on Overcoming Barriers [Series Home Page]

+Bipolar Disorder in Children and Adolescents [Series Home Page]

+Definition and Management of Suicidality in Psychiatric Patients [Series Home Page]

+Balancing the Equation: Managing Medical Comorbidities in Patients With Severe Mental Illness [Series Home Page]

+Expired Case & Comment [Series Home Page]

+Maintenance of Certification in Psychiatry [Series Home Page]

+Bipolar Depression [Series Home Page]

+What Is Depression? [Series Home Page]

+Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care [Series Home Page]

+MDD in Women: Focus on Reproductive Events [Series Home Page]

+Using Atypical Antipsychotics to Optimize the Clinical Management of Patients With Mental Illnesses [Series Home Page]

+Depression in the Elderly [Series Home Page]

+Insights Into Generalized Anxiety Disorder [Series Home Page]

+Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection [Series Home Page]

+ADHD and Comorbid Disorders in Adults [Series Home Page]

+A Critical Appraisal to Improve the Management of Schizophrenia [Series Home Page]

+Major Depressive Disorder [Series Home Page]

+Easing the Burden of Treatment-Resistant Depression [Series Home Page]

+Conference Coverage: 21st Annual European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Depression and Pain [Series Home Page]

+Depression, Pain, and Physical Symptoms [Series Home Page]

+Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission [Series Home Page]

+Understanding Fibromyalgia and Its Related Disorders [Series Home Page]

+Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap [Series Home Page]

+Clinical Insights Into Pharmacogenetics and Schizophrenia [Series Home Page]

+Pain and the Brain [Series Home Page]

+The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders [Series Home Page]

+Influencers of Treatment Success in Schizophrenia and Bipolar Disorder [Series Home Page]

+Maximizing Efficacy of Antidepressants Beyond Selective Serotonin Reuptake Inhibitors [Series Home Page]

+Conference Coverage: 20th European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Smoking Cessation in Patients With Psychiatric Disorders [Series Home Page]

+A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia [Series Home Page]

+Raising the Bar in Schizophrenia by Treating to Remission [Series Home Page]

+Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder [Series Home Page]

+Presentations From the Seventh International Conference on Bipolar Disorder [Series Home Page]

+Narcolepsy and Excessive Daytime Sleepiness: From the Bench to the Bedside [Series Home Page]

+Atypical Depression: Management Challenges and New Treatment Advances [Series Home Page]

+Cognitive Impairment Associated With Depression in the Elderly [Series Home Page]

+Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy [Series Home Page]

+Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness [Series Home Page]

+ADHD and Comorbid Substance Use Disorder [Series Home Page]

+Mixed Depression in Bipolar Disorders: Diagnosis and Treatment Strategies [Series Home Page]

+The Role of Folate in Depression and Dementia [Series Home Page]

+Strategies to Integrate Physical Health Care Into Mental Health [Series Home Page]

+Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment [Series Home Page]

+Translating Evidence on Depression and Physical Symptoms into Effective Clinical Practice [Series Home Page]

+Distance Rounds [Series Home Page]

+Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders [Series Home Page]

+The Art and Science of Switching Antipsychotic Medications [Series Home Page]

+Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness [Series Home Page]

+Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder [Series Home Page]

+Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia [Series Home Page]

+Exercise for Mood and Anxiety Disorders [Series Home Page]

+Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety [Series Home Page]

+Impact of Bipolar Disorder: Results From a Screening Study [Series Home Page]

+Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression [Series Home Page]

+Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond [Series Home Page]

+Practical Applications of Recent Antipsychotic Effectiveness Data [Series Home Page]

+Pathological Gambling: A Review of Phenomenological Models and Treatment Modalities for an Underrecognized Psychiatric Disorder [Series Home Page]

+ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function [Series Home Page]

+Practical Pharmacotherapeutic Management Strategies for Patients With Alcohol Dependence [Series Home Page]

+The Evolving View on Delta Sleep and Its Relationship to Daytime Function: A CME-Certified Virtual Symposium [Series Home Page]

+New Developments in Addiction Treatment [Series Home Page]

+Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient [Series Home Page]

+Improving Cognitive Function and Functional Outcome in Severe Mental Illness [Series Home Page]

+Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management [Series Home Page]

+Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms [Series Home Page]

+Managing Patients With Vascular Disease and Depression [Series Home Page]

+Use of Treatment Algorithms for Depression [Series Home Page]

+Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View [Series Home Page]

+New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

+Antecedents to Panic Disorder in Nonreferred Adults [Series Home Page]

+The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness [Series Home Page]

+A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer's Disease [Series Home Page]

+Emerging Therapies for Bipolar Depression [Series Home Page]

+The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment [Series Home Page]

+Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and Outcome [Series Home Page]

+Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents [Series Home Page]

+Distance Rounds [Series Home Page]

+Identifying and Managing Depression in the Medical Patient [Series Home Page]

+Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials [Series Home Page]

+Review of the Pharmacologic Management of Depression [Series Home Page]

+Bipolar Reports [Series Home Page]

+The Alzheimer's Disease Continuum: From Neuropathology to Clinical Practice [Series Home Page]

+The Impact of Disasters and Their Aftermath on Mental Health [Series Home Page]

+After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+The Recognition and Management of Bipolar Disorder With Comorbid Anxiety [Series Home Page]

+Focus on Bipolar Disorder Treatment [Series Home Page]

+Management of Autism and Its Related Disorders [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+New Therapies for Treatment-Resistant Depression and Anxiety [Series Home Page]

+Safety Issues With Drug Therapies for Autism Spectrum Disorders [Series Home Page]

+New Insights Into the Nature and Treatment of Panic Disorder [Series Home Page]

+The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder [Series Home Page]

+Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion [Series Home Page]

+New Perspectives in Treating Bipolar Disorder [Series Home Page]

+The Need for Better Management of Treatment-Resistant Depression [Series Home Page]

+Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness [Series Home Page]

+Beyond Refractory Obsessions and Anxiety States: Toward Remission [Series Home Page]

+New Perspectives for Treating Generalized Anxiety Disorder [Series Home Page]

+Recognizing the Physical Symptoms of Depression [Series Home Page]

+Clinical Effectiveness of Atypical Antipsychotics in Dementia [Series Home Page]

+Managing Bipolar Depression [Series Home Page]

+Drug-Induced Movement Disorders [Series Home Page]

+Using Atypical Antipsychotics in Primary Care [Series Home Page]

+Revisiting the Use of High-Potency Benzodiazepines [Series Home Page]

+Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults [Series Home Page]

+New Treatments for Depression Characterized by Physical Symptoms [Series Home Page]

+The Expert Consensus Guideline Series: Using Antipsychotic Agents in Older Patients [Series Home Page]

+Treating Aggressive Behavior in the Elderly [Series Home Page]

+Treating Depression: New Choices for a Chronic Problem [Series Home Page]

+Partial Compliance: The Need for Long-Acting Atypical Antipsychotics [Series Home Page]

+Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction [Series Home Page]

+The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders [Series Home Page]

+Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse [Series Home Page]

+Noncholinergic Treatments for Alzheimer’s Disease [Series Home Page]

+Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders [Series Home Page]

+Physical Symptoms of Depression and Their Impact on Patients and Society [Series Home Page]

+Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient? [Series Home Page]

+Management of Aggression Across the Life Cycle [Series Home Page]

+The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents [Series Home Page]

+Treating Depression and Anxiety to Remission: Use of Algorithms [Series Home Page]

+New Approaches to Managing Difficult-to-Treat Depressions [Series Home Page]

+Anxiety: New Treatment Perspectives [Series Home Page]